Sponsored by Johnson & Johnson and Bristol Myers Squibb
Industry attendance for this event is exclusive to only the sponsors of the Poster Session & Welcome Reception
Unlocking the Potential for a Bispecific Antibody in 3L+ DLBCL and 2L+ FL
Speaker: Jonathan Abbas, MD
Sponsored by Genmab and AbbVie
Industry attendance is limited to breakfast industry symposium sponsors only
Chairs:
Jesús Berdeja, MD (Greco-Hainsworth Tennessee Oncology Centers for Research)
Andrew Kuykendall, MD (Moffitt Cancer Center)
Joanna Rhodes, MD, MSCE (Rutgers Cancer Institute of New Jersey)
8:50 AM
Evolving Diagnostics in Iron Deficiency Anemia
Angela Weyand, MD (University of Michigan)
8:58 AM
The Bleeding Patient Consult
Michelle Chi, MD (Vanderbilt Health)
9:06 AM
New Developments in Sickle Cell Disease
Scott Peslak, MD, PhD (University of Pennsylvania)
9:14 AM
TTP/HUS
Spero Cataland, MD (The Ohio State University)
9:22 AM
Update in Venous Thromboembolism
Adam Cuker, MD, MS (University of Pennsylvania)
9:30 AM
Panel Discussion + Q&A
9:48 AM
MGUS/ SMM
Caitlin Costello, MD (University of California San Diego)
9:56 AM
CHIP/CCUS
Zhuoer Xie, MD, MS (Moffitt Cancer Center)
10:04 AM
MBL: Implications on Infectious Risk
Erin Mulvey, MD, MSCI (Weill Cornell Medicine)
10:12 AM
Panel Discussion + Q&A
11:00 AM
Debate: Single Agent Monotherapy vs Fixed Duration Combos in Frontline CLL
Moderator: Matthew Lunning, DO, FACP (University of Nebraska)
Adam Kittai, MD (Mount Sinai Health System)
Callie Coombs, MD (University of California Irvine)
11:20 AM
Multiple Myeloma
Amrita Krishnan, MD, FACP (City of Hope)
11:28 AM
Diffuse Large B-Cell Lymphoma
Ryan Lynch, MD (Fred Hutch Cancer Center)
11:36 AM
Hodgkin’s Lymphoma
Boyu Hu, MD (Huntsman Cancer Institute)
11:44 AM
Indolent Lymphomas
Elizabeth Brém, MD (University of California Irvine)
11:52 AM
Panel Discussion + Q&A
Reignite the Spark: Clinical Conversations about Jaypirca® (pirtobrutinib)
Speaker: Callie Coombs, MD (University of California Irvine)
Sponsored by Lilly
Industry attendance is limited to lunch industry symposium sponsor only
1:40 PM
Myeloproliferative Neoplasms
Gabriela Hobbs, MD (Massachusetts General Hospital)
1:48 PM
Myelofibrosis
John Mascarenhas, MD (Mount Sinai Health System)
1:56 PM
Chronic Myeloid Leukemia
Srinivas Tantravahi, MBBS, MRCP (Huntsman Cancer Institute)
2:04 PM
Myelodysplastic Syndromes
Anthony Hunter, MD (Winship Cancer Institute of Emory University)
2:12 PM
Panel Discussion + Q&A
2:32 PM
Defining High-Risk Disease in Lymphoid Malignancies
Jeremy Abramson, MD (Harvard Medical School)
2:40 PM
High-Risk Multiple Myeloma: Time For a Paradigm Change?
Natalie Callander, MD (University of Wisconsin)
2:48 PM
TP53-Mutated AML and MDS
David Sallman, MD (Moffitt Cancer Center)
2:56 PM
Panel Discussion + Q&A
3:45 PM
Multiple Myeloma in Patients with Frailty or Comorbidities
Rahul Banerjee, MD, FACP (Fred Hutch Cancer Center)
3:53 PM
How To Tackle Curative Intent in Lymphoma Patients With Cardiac Comorbidities
Sarah Rutherford, MD (Weill Cornell Medicine)
4:01 PM
MDS/MPN Overlap Syndromes
Eric Padron, MD (Moffitt Cancer Center)
4:09 PM
Debate: Intensive vs Less Intensive Induction For The Treatment of Older, But Fit, Patients With Newly Diagnosed AML
Moderator: Matthew Lunning, DO, FACP (University of Nebraska)
Dan Pollyea, MD, MS (University of Colorado School of Medicine)
Jeffrey Lancet, MD (Moffitt Cancer Center)
4:29 PM
Panel Discussion + Q&A
LYNOZYFIC in The Treatment of 5L+ Relapsed/Refractory Multiple Myeloma
Speaker: Sherif Farag, MD (Community Health Network MD Anderson Cancer Center Stem Cell Transplant & Cellular Therapy Institute)
Sponsored by Regeneron
Industry attendance is limited to breakfast industry symposium sponsor only
Chairs:
Jesús Berdeja, MD (Greco-Hainsworth Tennessee Oncology Centers for Research)
Andrew Kuykendall, MD (Moffitt Cancer Center)
Joanna Rhodes, MD, MSCE (Rutgers Cancer Institute of New Jersey)
8:45 AM
MRD in AML: Who, What, When, and How?
Rory Shallis, MD (Moffitt Cancer Center)
8:53 AM
Defining The Value of uMRD in CLL
Chaitra Ujjani, MD (Fred Hutch Cancer Center)
9:01 AM
MRD in Multiple Myeloma: How, When and Why?
Noopur Raje, MD (Massachusetts General Hospital)
9:09 AM
ctDNA in Lymphoma
Sairah Ahmed, MD (MD Anderson Cancer Center)
9:17 AM
Debate: Is Monotherapy Maintenance Until Progression The Optimal Approach To Maintenance Therapy in Multiple Myeloma in The Era of Quadruplet Induction?
Moderator: Matthew Lunning, DO, FACP (University of Nebraska)
Peter Voorhees, MD (Atrium Health Levine Cancer Institute)
Faith Davies, MD (NYU Langone Health)
9:37 AM
Panel Discussion + Q&A
9:55 AM
Multiple Myeloma
Mansi Shah, MD (Rutgers Cancer Institute of New Jersey)
10:03 AM
CLL
Jacqueline Barrientos, MD, MS (Mount Sinai Health System)
10:11 AM
Indolent Lymphomas
Krish Patel, MD (Sarah Cannon Research Institute)
10:19 AM
Acute Myeloid Leukemia
Rami Komrokji, MD (Moffitt Cancer Center)
10:27 AM
Panel Discussion + Q&A
11:15 AM
CAR-T in Multiple Myeloma
Krina Patel, MD (MD Anderson Cancer Center)
11:23 AM
CAR-T in Non-Hodgkin’s Lymphoma
Elise Chong, MD (University of Pennsylvania)
11:31 AM
Bispecifics in Multiple Myeloma
Susan Bal, MD (University of Alabama Birmingham)
11:39 AM
Bispecifics in Lymphomas
Tycel Phillips, MD (City of Hope)
11:47 AM
Managing Acute Toxicities with Cellular and T-cell Redirecting Therapies
Babis Andreadis, MD, MS (University of California San Francisco)
11:55 AM
Panel Discussion + Q&A
Optimal Sequencing in RRMM
Peter Voorhees, MD (Atrium Health Levine Cancer Institute)
Sponsored by Kite and Arcellx and Johnson & Johnson
Industry attendance is limited to lunch symposium sponsors only
1:55 PM
Utilizing Remote Consultation To Optimize Patient Care in The Community Setting
Jennifer Green, MD (Tennessee Oncology)
2:03 PM
Utilizing Frailty Indexes
Reena Jayani-Kosarzycki, MD, MSCI (Vanderbilt Health)
2:11 PM
Bringing Bispecifics to the Community
Tara Graff, DO, MS (Mission Cancer + Blood)
2:19 PM
Managing Long-Term Toxicities With Cellular and T-cell Redirecting Therapies
Adam Cohen, MD (University of Pennsylvania)
2:27 PM
Panel Discussion +Q&A
3:17 PM
Multiple Myeloma
Ajay Nooka, MD, MPH (Winship Cancer Institute of Emory University)
3:25 PM
CLL
Deborah Stephens, DO (University of North Carolina School of Medicine)
3:33 PM
Non-Hodgkin’s Lymphoma
Sameh Gaballa, MD (Moffitt Cancer Center)
3:41 PM
AML+MDS
Uma Borate, MBBS (The Ohio State University)
3:49 PM
MPNs +SM+CML
Kristen Pettit, MD (University of Michigan)
3:57 PM
Q&A
*Agenda is subject to change.
Experience Nashville, TN